BioMedNewsBreaks – MediXall Group Inc. (MDXL) Launches New Telehealth Solutions for Uninsured, Underinsured

MediXall Group (OTCQB: MDXL), a technology and innovation-driven organization focused on reducing costs of health care and transforming the patient-provider experience through the launch of its Health Karma(TM) platform, today announced new virtual-care solutions for the uninsured and underinsured. Effective immediately, Americans can conduct an online medical visit with a board-certified medical professional to get fast and easy treatment, prescriptions and lab tests for routine medical issues. This new service is a result of Health Karma’s recent partnership with leading telehealth company MeMD. “Telehealth will continue to be a popular option for patients, providers and employers beyond the pandemic,” Health Karma President Michael Swartz said in the news release. “It is a privilege for Health Karma to provide affordable virtual care for our users to ensure they get the care they need at a price that is accessible.”

Click here to view the full press release.

About MediXall Group Inc.

MediXall Group is a technology and innovation-driven organization purposefully designed and structured around delivering products and services to make it easier for consumers to learn, decide and pay for health care without intruding on the important relationship with trusted doctors. The mission of the MediXall Group is to revolutionize the medical industry by improving communication; providing better technology and support services; and enabling more efficient, cost-effective health care for the consumer. By approaching the health-care ecosystem as a whole, MediXall creates, invests and incubates companies that embody its mission statement. For more information, visit www.MediXallGroup.com.

About BioMedWire

BioMedWire (BMW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) BioMedNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. BMW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information please visit https://www.biomedwire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.biomedwire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork

Chris@BMW

Share
Published by
Chris@BMW

Recent Posts

BioMedNewsBreaks — Nutriband Inc. (NASDAQ: NTRB) CEO Named EY Entrepreneur of the Year 2025 Finalist in Established Category 

Nutriband (NASDAQ: NTRB) CEO Gareth Sheridan has been named a finalist in the Established category…

5 days ago

BioMedNewsBreaks – Calidi Biotherapeutics Inc. (NYSE American: CLDI) Receives FDA Clearance to Begin Trials for CLD-201 in Solid Tumors

Calidi Biotherapeutics (NYSE American: CLDI) announced FDA clearance of its Investigational New Drug application for CLD-201,…

5 days ago

BioMedNewsBreaks – ProPhase Labs Inc. (NASDAQ: PRPH) Closes $23.6M Sale to Focus on Core Businesses

ProPhase (NASDAQ: PRPH), a next-generation biotech, genomics, and diagnostics company, earlier this year announced the…

6 days ago

BioMedNewsBreaks — Bluejay Diagnostics Inc. (NASDAQ: BJDX) Secures $3.7M in Warrant Inducement Transaction 

Bluejay (NASDAQ: BJDX) is a medical technology company developing rapid diagnostics on its Symphony platform…

7 days ago

BioMedNewsBreaks – NextPlat Corp (NASDAQ: NXPL) Secures Military Contract Extension for Iridium PTT Services

NextPlat (NASDAQ: NXPL, NXPLW), a global e-commerce provider, announced that its subsidiary, Global Telesat Communications…

7 days ago

BioMedNewsBreaks — Soligenix Inc. (NASDAQ: SNGX) Announces Positive Data, Continued Advancement of HyBryte(TM)

Soligenix (NASDAQ: SNGX) is a late-stage biopharmaceutical company focused on developing and commercializing products to…

1 week ago